EcoDrugPlus

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSCSEG00000015396
Gene Symbol: LOC103394313
3 Cross references
174 Possible Orthologues:

Granzyme G-Like

Ensembl ID : ENSCSEG00000002648
Gene Symbol: LOC103399906
2 Cross references
1073 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1

Ensembl ID : ENSCSEG00000003327
Gene Symbol: LOC103378932
3 Cross references
212 Possible Orthologues:

Growth Hormone-Releasing Hormone Receptor

Ensembl ID : ENSCSEG00000000209
Gene Symbol: LOC103398124
2 Cross references
193 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCSEG00000004443
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCSEG00000018527
Gene Symbol: GUCY1A2
4 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCSEG00000004420
Gene Symbol: GUCY1B1
1 Cross references
211 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha

Ensembl ID : ENSCSEG00000000515
Gene Symbol: LOC103380988
3 Cross references
317 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1

Ensembl ID : ENSCSEG00000000594
Gene Symbol: LOC103380989
3 Cross references
305 Possible Orthologues:

Heat Shock Protein Hsp 90-Beta

Ensembl ID : ENSCSEG00000020742
Gene Symbol: LOC103380891
3 Cross references
355 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSCSEG00000012622
Gene Symbol: HMGB1
2 Cross references
498 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSCSEG00000007468
Gene Symbol: LOC103377997
3 Cross references
512 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).